Adenocyte
Haifa, IL · 1 known investors
Adenocyte develops LINFU (Low Intensity Non-Focused Ultrasound), a minimally invasive ultrasound technology for routine screening of the pancreas to detect pancreatic dysplasia and early-stage pancreatic cancer. The company serves clinical cancer screening for elevated- and average-risk patients, with laboratories in Haifa and Jerusalem and clinical development at the Technion and North American screening centers.
BiotechHealthtechMedical Devices
Founders & leadership
MR
Mark RutenbergFounder & CEO
AC
April CarpenterChief Commercial Officer
SK
Scott KormanDirector
RH
Robert HarowChief Financial Officer
FS
F. Scott CorbettChief Medical Officer
DE
Drore EisenMedical Research Director
DA
Dan AdamChief Technology Officer